Get the Stockscreener App
10.09
4.45%
0.43
Pre-market:
10.20
0.11
+1.09%
Delcath Systems Inc stock is traded at $10.09, with a volume of 461.38K.
It is up +4.45% in the last 24 hours and up +11.12% over the past month.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$9.66
Open:
$9.67
24h Volume:
461.38K
Relative Volume:
0.53
Market Cap:
$356.32M
Revenue:
$2.07M
Net Income/Loss:
$-47.68M
P/E Ratio:
-3.578
EPS:
-2.82
Net Cash Flow:
$-31.31M
1W Performance:
+4.67%
1M Performance:
+11.12%
6M Performance:
-38.40%
1Y Performance:
-11.72%
1-Day Range:
$9.57
$10.12
1-Week Range:
$9.25
$10.12
52-Week Range:
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
10.09 | 341.13M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
125.40 | 217.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.72 | 146.12B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.35 | 139.95B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.99 | 130.73B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 48.73B | 5.88B | 1.34B | 799.60M | 2.3489 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Craig Hallum | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-26-22 | Resumed | Canaccord Genuity | Buy |
| Dec-10-21 | Initiated | H.C. Wainwright | Buy |
| Mar-09-21 | Initiated | Canaccord Genuity | Buy |
| Jan-05-21 | Initiated | BTIG Research | Buy |
| Jun-01-20 | Initiated | Laidlaw | Buy |
View All
Delcath Systems Inc Stock (DCTH) Latest News
How Delcath Systems Inc. (DV3R) stock reacts to Fed tighteningPortfolio Risk Summary & Daily Stock Trend Watchlist - Newser
Delcath Systems authorizes $25 million share repurchase program - MSN
How higher bond yields impact Delcath Systems Inc. (DV3R) stockProfit Target & AI Forecasted Stock Moves - Newser
Why Delcath Systems Inc. (DV3R) stock trades below fair valueQuarterly Trade Report & Daily Stock Trend Reports - Newser
Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma - BioSpace
Delcath reports 29-month survival in liver cancer treatment study By Investing.com - Investing.com Nigeria
Delcath Systems (DCTH) Showcases Promising Study Results for Liv - GuruFocus
Delcath Systems (Nasdaq: DCTH) details 10-year CHEMOSAT PHP outcomes in liver mUM - Stock Titan
Is Delcath Systems Inc. stock a top pick in earnings seasonJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - Newser
Investors in Delcath Systems (NASDAQ:DCTH) have seen splendid returns of 221% over the past three years - Yahoo Finance
(DCTH) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Delcath Systems (DCTH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Delcath Systems (DCTH) Competitors and Alternatives 2025 - MarketBeat
Dir Sylvester Buys 4,386 ($39K) Of Delcath Sys Inc [DCTH] - TradingView
DCTH insider Form 4 shows director purchase and 14,936-share stake - Stock Titan
Do Options Traders Know Something About Delcath Systems Stock We Don't? - Nasdaq
Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and ClearPoint Neuro (CLPT) - The Globe and Mail
Delcath Systems (NASDAQ:DCTH) Board Authorizes Stock Repurchase Plan - MarketBeat
Responsive Playbooks and the DCTH Inflection - news.stocktradersdaily.com
Why We're Not Concerned Yet About Delcath Systems, Inc.'s (NASDAQ:DCTH) 28% Share Price Plunge - simplywall.st
Delcath Systems authorizes $25 million share repurchase program By Investing.com - Investing.com Canada
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program - BioSpace
How supply shortages influence Delcath Systems Inc. (DV3R) stockEarnings Growth Summary & Entry and Exit Point Strategies - newser.com
Biotech Stocks Swing After Hours: Delcath Rises On Buyback, BioVie And Cassava Rebound - Nasdaq
Delcath Systems board authorizes $25 million share repurchase program By Investing.com - Investing.com Australia
Delcath Systems board authorizes $25 million share repurchase program - Investing.com India
Delcath Systems (DCTH) Initiates $25 Million Share Buyback Progr - GuruFocus
Delcath Systems Announces $25M Share Buyback Plan - TipRanks
[8-K] DELCATH SYSTEMS, INC. Reports Material Event | DCTH SEC FilingForm 8-K - Stock Titan
Delcath Systems, Inc. announces an Equity Buyback for $25 million worth of its shares. - marketscreener.com
Delcath Systems board of directors authorizes $25 million share repurchase program - MarketScreener
Domino's Pizza (Nasdaq: DPZ) brings back $9.99 any-topping pizzas promotion - Stock Titan
Can Delcath Systems Inc. (DV3R) stock beat analyst consensusWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com
Can Delcath Systems Inc. (DV3R) stock attract ESG investmentsWeekly Loss Report & Technical Analysis for Trade Confirmation - newser.com
What analyst consensus says on Delcath Systems Inc. stockBear Alert & Verified Trade Idea Suggestions - newser.com
Forecasting Delcath Systems Inc. price range with options dataJuly 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
Delcath Systems Shares Tick Higher After Study Highlights Strong Outcomes for Liver Cancer Treatment - MSN
Will Delcath Systems Inc. stock reach all time highs in 2025Market Performance Recap & AI Driven Stock Price Forecasts - newser.com
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.89%
4.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):